Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,245.00    5.00 (0.40%)
Bid:
1,230.00
Ask:
1,260.00
Spread: 30.00 (2.439%)
Market Cap: £367.78m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

7 Nov 2006 07:02

Celtic Resources Holdings PLC07 November 2006 Embargoed for 7.05am 7 NOVEMBER 2006 Celtic Resources Holdings Plc ("Celtic" or "the Company") TRADING UPDATE AND ADDITIONAL NOTES ON COMPETENT PERSONS REPORT IN EUREKA MINING PLC CIRCULAR Celtic announced today that the boards of Celtic and Eureka Mining PLC("Eureka") have agreed to the terms of a scheme of arrangement under s.425 ofthe Companies Act whereby Celtic will acquire Eureka (the "Scheme"). The detailsof the Scheme are contained in a separate announcement also released today. Thefull text of the associated Scheme circular to Eureka shareholders will be madeavailable on the Company's website, www.celticresources.com, when the Circularhas been posted to Eureka shareholders. The Circular contains a trading updateby Celtic: CURRENT TRADING Monthly gold production at Suzdal has been increasing and the BIOX(R) plant hascompleted an annual cycle which in Kazakhstan covers climatic temperatures from-40degreesC to +40degreesC. Improvements in plant throughput and gold recoveryare continuing. In addition, consideration is being given to expanding thecapacity of the plant to treat concentrates from other sources, including minesin the region which have sulphide ores similar to Suzdal. Since the interim results, published on 12 September 2006, internal forecastshave been reviewed and due to lower mined grades at Suzdal, Celtic now expectsgold production this year to be around 50,000 ozs. Also, due to treatment oflower grade transitional ores at Zherek, production there should be around12,000 ozs of gold this year. At 62,000 ozs, the combined group production willbe 60% higher than last year. At Zherek, Celtic's preliminary technical and economic studies suggest thatsulphide ore could be mined and trucked to Suzdal. Celtic continues to reviewother mining opportunities, primarily in the FSU. COMPETENT PERSONS REPORT SRK has completed a Competent Persons Report on Celtic's assets for the purposesof the Scheme circular, the full text of which is available in the Schemecircular. This included their resources audit that brought all reserve andresource statements into JORC Code as stated in Celtic's 2005 annual report andaccounts. Kevin Foo, Managing Director commented "The Company is pleased that SRK hasconfirmed a 2 million ozs JORC compliant gold resource. The BIOX(R) plant atSuzdal has demonstrated its robustness over the year and we are now consideringan expansion of the plant from capacity 300,000 t/y to 400,000 t/y. This willallow us to process additional Suzdal ore, Zherek ore and other refractory oresand concentrates in the region, thus taking advantage of the fact that ours isthe first successful application of bacterial oxidation in the FSU. " Notes: Terms in this press release shall have the same meaning as the terms inthe Eureka Scheme circular which will be posted to Eureka shareholders today(and will also be made available on Celtic's website). The Mineral ResourceStatement has been prepared by SRK under the JORC code. For further information please contact: Kevin Foo / Kate Dexter Smith Laurence ReadCeltic Resources Holdings Plc Conduit PRTel: + 44 (0)20 7921 8800 Tel: +44(0)20 7429 6666Investors@celticresources.com laurence@conduitpr.com Frank Moxon / Simon EdwardsEvolution Securities LimitedTel: +44 (0) 20 7071 4300 www.celticresources.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Feb 20209:57 amRNSResult of AGM
8th Jan 20208:58 amRNSHolding(s) in Company
8th Jan 20207:00 amRNSNotice of AGM
27th Nov 20192:52 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSHolding(s) in Company
28th Oct 20197:00 amRNSTrading Update
14th Oct 20197:00 amRNSMajor Contract Win
26th Sep 20194:49 pmRNSHolding(s) in Company
9th Sep 20197:00 amRNSMajor New Contract Win
8th Aug 20194:14 pmRNSHolding(s) in Company
8th Aug 20194:13 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSMajor Contract Win
14th Jun 20197:00 amRNSMajor New Contract Win
20th May 20197:00 amRNSInterim Results
2nd May 20197:00 amRNSTrading Update and Notice of Results
21st Feb 20197:00 amRNSGartner Magic Quadrant Report
14th Feb 20194:01 pmRNSEmployee Share Option Scheme
13th Feb 20197:00 amRNSMajor New Contract Win
8th Feb 20193:16 pmRNSResult of AGM
25th Jan 20196:03 pmRNSNotice of AGM
26th Nov 20187:00 amRNSFinal Results
22nd Oct 20187:00 amRNSTrading Update
30th May 20187:00 amRNSTM Forum's 2018 Catalyst Awards
14th May 20187:00 amRNSInterim Results
16th Apr 20187:25 amRNSTrading Update & Notice of Results
5th Feb 201810:21 amRNSResult of AGM
17th Jan 20187:00 amRNSNotice of AGM and Posting of Annual Report
5th Dec 20177:00 amRNSMajor Contract Win
27th Nov 20177:00 amRNSFinal Results
17th Nov 20177:00 amRNSChange of Registered Office
30th Oct 20177:00 amRNSGartner Magic Quadrant Report
30th Oct 20177:00 amRNSTrading Update
20th Sep 20174:33 pmRNSHolding(s) in Company
19th Sep 20174:39 pmRNSImplementation of Long Term Incentive Plan
26th May 201710:13 amRNSCompletion of Director Placing
25th May 20175:00 pmRNSProposed Director Placing
22nd May 20177:00 amRNSInterim Results
9th May 20177:00 amRNSNotice of Results
10th Apr 20177:00 amRNSTrading Update
17th Mar 20177:00 amRNSMajor Contract Win
8th Feb 20174:11 pmRNSRe: New Employee Share Option Scheme
11th Jan 20175:47 pmRNSNotice of AGM and Posting of Annual Report
6th Jan 20177:00 amRNSNew Employee Share Option Scheme
21st Dec 20167:00 amRNSMajor Contract Win
1st Dec 20165:38 pmRNSRevised Dividend Timetable
28th Nov 20167:00 amRNSMajor Contract Win
28th Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSRe: Gartner's 2016 Magic Quadrant report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.